CMRX

Chimerix (CMRX)

About Chimerix (CMRX)

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Details

Daily high

$3.20

Daily low

$2.80

Price at open

$2.85

52 Week High

$3.39

52 Week Low

$0.75

Market cap

268.9M

Dividend yield

0.00%

Volume

2.5M

Avg. volume

12.2M

P/E ratio

-3.20

Chimerix News